EW vs LESL · P/E 47, rev $3.39B vs rev $790.4M
Edwards Lifesciences Corp (EW) versus Leslies Inc (LESL) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Leslies Inc (LESL) is a specialty retail company listed on NASDAQ.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported LESL revenue for 2026-07-04 was $790.4M. Net income was -$87.7M. LESL currently screens at market cap $71.9M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. LESL currently screens at market cap $71.9M.
Not investment advice. Open the EW and LESL stock pages for the full models.
Not investment advice.